The Australian Research Data Commons (ARDC) invites you to participate in a short survey about your
interaction with the ARDC and use of our national research infrastructure and services. The survey will take
approximately 5 minutes and is anonymous. It’s open to anyone who uses our digital research infrastructure
services including Reasearch Link Australia.
We will use the information you provide to improve the national research infrastructure and services we
deliver and to report on user satisfaction to the Australian Government’s National Collaborative Research
Infrastructure Strategy (NCRIS) program.
Please take a few minutes to provide your input. The survey closes COB Friday 29 May 2026.
Complete the 5 min survey now by clicking on the link below.
Clinical And Physiological Features Of Obstructive Sleep Apnoea Phenotypes
Funder
National Health and Medical Research Council
Funding Amount
$117,331.00
Summary
Obstructive sleep apnoea has variable causes and clinical effects in different patient groups. My research will quantify the contribution of various physiological processes to the development of upper airway obstruction in different sub-types of sleep apnoea and to determine how this affects clinical presentation. I will be measuring a number of physiological parameters, and finding out how sleep apnoea manifests in terms of symptomatology and adverse health effects.
A Prospective Multicentre Randomized Study To Evaluate The Impact Of OSA Treatment With CPAP On Atrial Electrical And Structural Substrate And On Long Term Maintenance Of Sinus Rhythm Following Catheter Ablation Of Atrial Fibrillation
Funder
National Health and Medical Research Council
Funding Amount
$128,224.00
Summary
Atrial fibrillation(AF) is the commonest heart rhythm disorder causing stroke, heart failure and increased mortality. Similarly, obstructive sleep apnea(OSA) is increasingly recognised as a modern epidemic. Epidemiological data have demonstrated an independent association between the two conditions. We will conduct a prospective multicenter randomized study to evaluate the impact of OSA treatment on: (i)maintenance of sinus rhythm after catheter ablation of AF, (ii)atrial structure and function
Chronotherapy For Hypertension In Obstructive Sleep Apnoea
Funder
National Health and Medical Research Council
Funding Amount
$57,921.00
Summary
This randomised, double blind placebo controlled cross-over trial aims to determine whether evening ingestion of blood pressure medication results in superior blood pressure control as compared to morning ingestion in patients with high blood pressure and obstructive sleep apnoea.
Early Detection Of Pulmonary Exacerbation In Cystic Fibrosis Using Nocturnal Measurements Of Cough And Sleep
Funder
National Health and Medical Research Council
Funding Amount
$140,949.00
Summary
Cystic Fibrosis (CF), the most common lethal inherited disorder effecting Australians, is a medical success story, with survival increasing from 5 years in 1970 to 40 years now. However, lower respiratory tract infections remain the major problem in CF. This project will develop and test a simple, non-invasive device to detect early chest infections, allowing early treatment, improving quality of life and preventing lung scarring. Less hospitalisations will benefit both patients and hospitals.
Towards Better Management Of Obstructive Sleep Apnoea In Chronic Tetraplegia
Funder
National Health and Medical Research Council
Funding Amount
$71,636.00
Summary
Approximately 50% of people with tetraplegia have obstructive sleep apnoea (OSA); a condition where their throat closes during sleep. OSA is known to make living with tetraplegia much more difficult. This project aims to develop a way to screen for OSA in tetraplegia without a full sleep study (an expensive and often inaccessible test) and to understand the issues faced by clinicians in managing OSA in this group of patients so that strategies can be designed to improve diagnosis and treatment.
How Does Fampridine Affect Upper Limb Function In Multiple Sclerosis?
Funder
National Health and Medical Research Council
Funding Amount
$113,237.00
Summary
Multiple sclerosis (MS) is a common and disabling neurological disease affecting thousands of young Australians. In 2011 Fampridine received TGA approval for walking impairment in MS, but its mechanism of action is unknown and its effects on domains other than lower limb function remain untested. Our study will test whether Fampridine improves upper limb impairment in MS patients and will use electrophysiological measures of central nervous system conduction to uncover its mechanism of action.
The Next Generation Of Impact In Cystic Fibrosis - Adolescent Mental Health And Beyond
Funder
National Health and Medical Research Council
Funding Amount
$76,365.00
Summary
My project studies adolescents with cystic fibrosis and explore how mental health issues influence and associate with important health outcomes relating to respiratory health, sleep quality, pain issues, family functioning, financial and social status and ability to manage treatment plans. I will recruit participants from the AREST CF (Australian Respiratory Early Surveillance Team for Cystic Fibrosis) project that studies children with CF from diagnosis.
Sleep-disordered Breathing In Pregnancy-induced Hypertension And Preeclampsia: Maternal And Fetal Outcomes
Funder
National Health and Medical Research Council
Funding Amount
$129,559.00
Summary
Our study aims to compare signs of sleep-disordered breathing (such as snoring and breathing pauses) in pregnant women affected by hypertension or preeclampsia to those with a healthy pregnancy, and to see if they respond differently to the breathing problems. To do this we will examine whether snoring and breathing pauses during sleep have an impact on the pregnant woman’s blood pressure and the unborn baby’s heart rate overnight, and scans will monitor whether the baby’s growth is affected.
Neurobiology Of Relaxin-3/RXFP3 Systems: Anatomical And Functional Studies In Transgenic Mice
Funder
National Health and Medical Research Council
Funding Amount
$94,242.00
Summary
Mental illness is an economic and health burden worldwide, with huge costs in medical spending, lost productivity, poor quality of life for sufferers and mortality. Relaxin-3 is a peptide that acts widely within neural circuits to modulate brain activity that is altered in conditions such as anxiety and mood/sleep disorders. Our research assessing the effect of genetic removal of relaxin-3 signaling on behaviour will add to our knowledge of brain function and improve mental health outcomes.
Sleep, Telomere Length And Cardiorespiratory Phenotype In 11-12 Year Old Children: Cross-sectional Australian National Population Based Study
Funder
National Health and Medical Research Council
Funding Amount
$84,800.00
Summary
Telomeres are special areas at the ends of our chromosomes that ‘protect’ our DNA as our body cells divide. With ageing, our telomeres slowly become shorter, but the rate at which this happens varies. My project will investigate the associations between poor sleep duration and quality, increased risk of cardiovascular diseases, poor respiratory health and increased vulnerability to viral infections to shorter telomere length.